thromboxanes has been researched along with Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bistrup, C; Diatchikhine, M; Jensen, BL; Lund, L; Madsen, K; Mogensen, AK; Nilsson, L; Nüsing, R; Nørregaard, R; Tofteng, SS | 1 |
| Kalkman, EA; Saxena, PR; Schoemaker, RG; van Dijk, JP; van Suylen, RJ | 1 |
2 other study(ies) available for thromboxanes and Cirrhosis
| Article | Year |
|---|---|
Increased COX-2 after ureter obstruction attenuates fibrosis and is associated with EP
Topics: Animals; Cyclooxygenase 2; Dinoprostone; Fibrosis; Humans; Kidney; Mice; Prostaglandins E; Prostaglandins I; Receptors, Prostaglandin E, EP2 Subtype; RNA, Messenger; Thromboxanes; Up-Regulation; Ureter; Ureteral Obstruction | 2022 |
Chronic aspirin treatment affects collagen deposition in non-infarcted myocardium during remodeling after coronary artery ligation in the rat.
Topics: Animals; Aspirin; Collagen; Coronary Vessels; Dose-Response Relationship, Drug; Eicosanoids; Endothelium; Epoprostenol; Fibrosis; Heart; Ligation; Male; Myocardial Infarction; Rats; Rats, Wistar; Thromboxanes; Ventricular Function, Left | 1995 |